Trial Profile
A Study to Evaluate the Potential for Pharmacokinetic Interaction Between SB 462795 and SSRIs in Healthy Subjects [3A]
Status:
Completed
Phase of Trial:
Phase I
Latest Information Update: 06 Sep 2023
Price :
$35
*
At a glance
- Drugs Relacatib (Primary) ; Atorvastatin; Ibuprofen; Paracetamol
- Indications Osteoarthritis; Osteoporosis
- Focus Pharmacokinetics
- Sponsors GSK
- 20 Apr 2008 Status changed from in progress to completed.
- 03 Jan 2007 New trial record.